Analysis Link Pharma Chem Limited (LINKPH)
6/2/2024
Analysis of Link Pharma Chem Limited (LINKPH)
Link Pharma Chem Limited has been showing some volatility in its stock price recently. The Relative Strength Index (RSI) values have been fluctuating around the 40-50 range, indicating a neutral to slightly bearish sentiment in the market.The Moving Average Convergence Divergence (MACD) indicator has been hovering around the zero line, suggesting a lack of strong trend in either direction. The MACD histogram has been mostly negative, indicating some downward pressure on the stock price.
The Moving Average (MA) indicator has been close to the actual stock price, indicating that the stock has been trading close to its average price over the specified period.
Overall, based on the RSI, MACD, and MA indicators, it seems that Link Pharma Chem Limited is currently experiencing a period of consolidation or uncertainty in the market. Traders and investors may want to closely monitor the stock for any potential breakout or trend reversal in the near future.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company. Here is a summary of the key data points:Financials:
- Cash flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit margin: 26.306%
- Fiscal year ends: September 30, 2023
- Income statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating margin: 30.743%
- Return on assets TTM: 22.073999%
- Return on equity TTM: 147.25%
Stock statistics:
- Short ratio: 1.53
- Float shares: 15,308,320,742
- Shares short: 99,287,450
- Average 10-day volume: 46,860,048
- Average 90-day volume: 57,498,254
- Shares outstanding: 15,334,099,968
- Percent held by insiders: 5.22%
- Percent held by institutions: 57.589%
- Short percent of shares outstanding: 0.65%
Valuations metrics:
- PEG ratio: 26.319502
- Forward PE: 26.319502
- Trailing PE: 29.59409
- Enterprise value: $2,950,762,332,160
- Price to book MRQ: 39.3405
- Price to sales TTM: 7.646095
- Enterprise to EBITDA: 22.763
- Enterprise to revenue: 7.732
- Market capitalization: $2,917,925,650,432
Stock price summary:
- Beta: 1.264
- 50-day moving average: $176.2646
- 200-day moving average: $181.0429
- 52-week low: $164.08
- 52-week high: $199.62
- 52-week change: 6.853%
Dividends and splits:
- Payout ratio: 14.93%
- Dividend date: May 16, 2024
- Last split date: August 31, 2020
- Ex-dividend date: May 10, 2024
- Last split factor: 4-for-1 split
- Forward annual dividend rate: $1
- 5-year average dividend yield: 0.73%
- Forward annual dividend yield: 0.5255%
- Trailing annual dividend rate: $0.97
- Trailing annual dividend yield: 0.5097%
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in sales from FY 2022 to FY 2023.
- Prior to the decrease, there was a consistent growth in sales over the previous years.
- The highest sales figure was recorded in FY 2022.
These trends indicate fluctuations in the company's revenue performance, with a notable decline in the most recent fiscal year.
Balance Sheet
These are balance sheets. Here are the conclusions based on the provided data:1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets fluctuate slightly from year to year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $209,017,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2023 at $62,146,000,000.
6. The company has been relying more on non-current assets to support its operations over the years.
7. There is a significant amount of debt in the company's capital structure, both short-term and long-term.
8. The company has been investing in leases, land, and improvements, as well as machinery, furniture, and equipment to support its operations.
9. Retained earnings have been negative in some years, indicating losses or dividend payouts exceeding profits.
10. The company has been managing its cash and cash equivalents effectively, with fluctuations in other current assets.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 in the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, with a sales growth of 2% compared to the same period last year. The number of analysts providing estimates is 25.
Looking at the next quarter ending on September 30, 2024, the average estimate increases to $85,501,800,000, with a sales growth of 3% compared to the previous year. Again, 25 analysts have contributed to these estimates.
For the current fiscal year ending on September 30, 2024, the average estimate for total revenue is $357,772,000,000, showing a 1% growth from the previous year. The number of analysts providing estimates for the full year is 38.
In the following fiscal year ending on September 30, 2025, the average estimate for total revenue is projected to be $380,772,000,000, indicating a more significant growth of 6% compared to the previous fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in both the short term and the long term, with a slightly more optimistic outlook for the upcoming fiscal year.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slight increase in growth rate expected in the coming years compared to the current period. However, the growth rate is projected to be lower than the average growth rate observed in the past 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions regarding the future price of the security, with the majority clustering around the median and average values. The current price is below both the median and average forecast, suggesting that there may be potential upside according to analysts' predictions.
MACD of LINKPH
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
